C. Russell Trenary III
2023
In 2023, C. Russell Trenary III earned a total compensation of $1.8M as President and Chief Executive Officer at Outlook Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,147,963 |
|---|---|
| Salary | $600,000 |
| Other | $10,899 |
| Total | $1,758,862 |
Trenary received $1.1M in option awards, accounting for 65% of the total pay in 2023.
Trenary also received $600K in salary and $10.9K in other compensation.
Rankings
In 2023, C. Russell Trenary III's compensation ranked 517th out of 1,932 executives tracked by ExecPay. In other words, Trenary earned more than 73.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 517 out of 1,932 | 73rd |
Division Manufacturing | 276 out of 1,028 | 73rd |
Major group Chemicals And Allied Products | 189 out of 573 | 67th |
Industry group Drugs | 188 out of 549 | 66th |
Industry Biological Products, Except Diagnostic Substances | 60 out of 129 | 54th |
Source: SEC filing on February 8, 2024.
Trenary's colleagues
We found two more compensation records of executives who worked with C. Russell Trenary III at Outlook Therapeutics in 2023.